Application of a point-of-care testing full blood count analyser in neonatal (<2 months) clinical care

Application of POCT FBC analyser in neonatal (<2 months) clinical care

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN76433651

Enrollment

Registered

2025-12-29

Start date

2024-11-01

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonates < 2 months' blood samples are sometimes clotted when they reach the laboratory for full blood count (FBC) analysis, leading to repeat sampling and delays in results. Pregnancy and Childbirth

Interventions

This study looks at the feasibility of using a point-of-care testing device (Hemoscreen) for full blood count (FBC) analysis. The device will be placed on the neonatal unit, and samples will be analys

Eligibility

Sex/Gender

All

Age

0 Months to 2 Months

Inclusion criteria

Inclusion criteria: < 2 months of age. No more than 2 samples used per patient

Exclusion criteria

Exclusion criteria: Patients without consent and patients > 2 months of age

Design outcomes

Primary

Measure	Time frame
Full blood count collected and measured at the point-of-care using the Pixcell Medical Hemoscreen device versus the hospital laboratory using a Sysmex XN1000 analyser at one time point.	—

Secondary

Measure	Time frame
The percentage of samples that can be processed at the point-of-care on the Pixcell Haemoscreen, but are clotted by the time of receipt in the laboratory, measured using laboratory records at one timepoint	—

Countries

England, United Kingdom

Contacts

Public ContactNuthar Jassam

nuthar.jassam@nhs.net+44 (0)1423 555647

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026